APC |
Antigen-presenting cells |
CAR-T |
Chimeric antigen receptor T |
ChT |
Chemotherapy |
COG |
Children’s Oncology Group |
DC |
Dendritic cells |
GM-CSF |
Granulocyte-macrophage colony stimulating factor |
HER2 |
Human Epidermal growth factor Receptor 2 |
Hh |
Hedgehog |
ICI |
Immune checkpoint inhibitors |
IGF |
Insulin-like growth factor |
IGF-1R |
IGF-1 receptor |
IL |
Interleukin |
INF |
Interferon |
miRNA |
microRNA |
mTOR |
Mammalian target of rapamycin |
NK |
Natural killer |
OS |
Osteosarcoma |
PD-L1 |
Programmed cell death ligand 1 |
PD-1 |
Programmed cell death protein 1 |
PDGF |
Platelet-derived growth factor |
PDGFR |
Platelet-derived growth factor receptor |
PD-L1 |
Programmed cell death ligand 1 |
Ptch |
Patched |
PTHrP |
Parathyroid hormone- related peptide |
RANKL |
Receptor activator of nuclear factor kappa-Β ligand |
Smo |
Smoothened |
TGF |
Transforming growth factor |
Th |
T-helper |
TNF |
Tumor necrosis factor |
Treg |
Regulatory T cells |
uPA |
Urokinase plasminogen activator |
VEGF |
Vascular endothelial growth factor |